General Information of the Protein
Protein ID
PT01996
Protein Name
Bombesin receptor subtype-3
Gene Name
BRS3
Sequence
MAQRQPHSPNQTLISITNDTESSSSVVSNDNTNKGWSGDNSPGIEALCAIYITYAVIISVGILGNAILIKVFFKTKSMQTVPNIFITSLAFGDLLLLLTCVPVDATHYLAEGWLFGRIGCKVLSFIRLTSVGVSVFTLTILSADRYKAVVKPLERQPSNAILKTCVKAGCVWIVSMIFALPEAIFSNVYTFRDPNKNMTFESCTSYPVSKKLLQEIHSLLCFLVFYIIPLSIISVYYSLIARTLYKSTLNIPTEEQSHARKQIESRKRIARTVLVLVALFALCWLPNHLLYLYHSFTSQTYVDPSAMHFIFTIFSRVLAFSNSCVNPFALYWLSKSFQKHFKAQLFCCKAERPEPPVADTSLTTLAVMGTVPGTGSIQMSEISVTSFTGCSVKQAEDRF
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Peptide receptor (family A GPCR)
>
Short peptide receptor (family A GPCR)
>
GRP-related receptor
Function
Role in sperm cell division, maturation, or function. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.
    Show/Hide
Uniprot ID
P32247
HGNC ID
HGNC:1113
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0471153
2-[[[2-(4-chlorophenyl)acetyl]amino]carbamoylamino]-3-(1H-indol-3-yl)-N-(2-phenylethyl)propanamide
   Show/Hide
C28H28ClN5O3
 1
1
EC50 = 0.19 nM
   TI
   LI
   LO
   TS
CP0448059
3-(1H-indol-3-yl)-N-(2-phenylethyl)-2-[[(2-pyridin-3-ylacetyl)amino]carbamoylamino]propanamide
   Show/Hide
C27H28N6O3
 1
1
EC50 = 1.4 nM
   TI
   LI
   LO
   TS
CP0857821
peptidomimetic
   Show/Hide
C25H25N5O3
 1
1
EC50 = 1.5 nM
   TI
   LI
   LO
   TS
CP0857820
3-(1H-Indol-3-yl)-N-phenethyl-2-(2-phenylacetylamino-propionylamino)-propionamide
   Show/Hide
C30H32N4O3
 1
1
EC50 = 2.1 nM
   TI
   LI
   LO
   TS
CP0511263
3-(1H-indol-3-yl)-2-[[[2-(1H-indol-2-yl)acetyl]amino]carbamoylamino]-N-(2-phenylethyl)propanamide
   Show/Hide
C30H30N6O3
 1
1
EC50 = 2.2 nM
   TI
   LI
   LO
   TS
CP0448017
2-[2-(4-Chloro-benzylamino)-acetylamino]-3-(1H-indol-3-yl)-N-phenethyl-propionamide
   Show/Hide
C28H29ClN4O2
 1
1
EC50 = 2.9 nM
   TI
   LI
   LO
   TS
CP0486296
3-(1H-indol-3-yl)-2-[[(2-phenylacetyl)amino]carbamoylamino]-N-(2-phenylethyl)propanamide
   Show/Hide
C28H29N5O3
 1
1
EC50 = 3.1 nM
   TI
   LI
   LO
   TS
CP0882215
2-(4-Chloro-benzylamino)-N-[2-(1H-indol-3-yl)-1-phenethylcarbamoyl-ethyl]-propionamide
   Show/Hide
C29H31ClN4O2
 1
1
EC50 = 4 nM
   TI
   LI
   LO
   TS
CP0377473
2-[[(4-chlorophenyl)methylamino]carbamoylamino]-3-(1H-indol-3-yl)-N-(2-phenylethyl)propanamide
   Show/Hide
C27H28ClN5O2
 1
1
EC50 = 6 nM
   TI
   LI
   LO
   TS
CP0905375
2-[2-(2-Benzo[1,3]dioxol-5-yl-acetylamino)-propionylamino]-3-(1H-indol-3-yl)-N-phenethyl-propionamide
   Show/Hide
C31H32N4O5
 1
1
EC50 = 7.8 nM
   TI
   LI
   LO
   TS
CP0395240
3-(1H-indol-3-yl)-N-(2-phenylethyl)-2-[[[2-(1,2,3,4-tetrahydroisoquinolin-1-yl)acetyl]amino]carbamoylamino]propanamide
   Show/Hide
C31H34N6O3
 1
1
EC50 = 9.3 nM
   TI
   LI
   LO
   TS
CP0397557
2-[(benzylamino)carbamoylamino]-3-(1H-indol-3-yl)-N-(2-phenylethyl)propanamide
   Show/Hide
C27H29N5O2
 1
1
EC50 = 15 nM
   TI
   LI
   LO
   TS
CP0478311
3-(1H-Indol-3-yl)-N-phenethyl-2-(2-phenethylamino-acetylamino)-propionamide
   Show/Hide
C29H32N4O2
 1
1
EC50 = 17 nM
   TI
   LI
   LO
   TS
CP0409901
(2R)-3-(1H-indol-3-yl)-N-(2-phenylethyl)-2-[[[2-(1,2,3,4-tetrahydroisoquinolin-1-yl)acetyl]amino]carbamoylamino]propanamide
   Show/Hide
C31H34N6O3
 1
1
EC50 = 19 nM
   TI
   LI
   LO
   TS
CP0395140
3-(1H-Indol-3-yl)-N-phenethyl-2-{2-[(pyridin-3-ylmethyl)-amino]-acetylamino}-propionamide
   Show/Hide
C27H29N5O2
 1
1
EC50 = 21 nM
   TI
   LI
   LO
   TS
CP0448521
2-(2-Benzylamino-acetylamino)-3-(1H-indol-3-yl)-N-phenethyl-propionamide
   Show/Hide
C28H30N4O2
 1
1
EC50 = 21 nM
   TI
   LI
   LO
   TS
CP0409874
2-[(furan-2-ylmethylamino)carbamoylamino]-3-(1H-indol-3-yl)-N-(2-phenylethyl)propanamide
   Show/Hide
C25H27N5O3
 1
1
EC50 = 24 nM
   TI
   LI
   LO
   TS
CP0902641
N-[2-(1H-Indol-3-yl)-1-phenethylcarbamoyl-ethyl]-2-phenethylamino-propionamide
   Show/Hide
C30H34N4O2
 1
1
EC50 = 25 nM
   TI
   LI
   LO
   TS
CP0376725
2-[2-(4-Benzyl-piperidin-1-yl)-acetylamino]-3-(1H-indol-3-yl)-N-phenethyl-propionamide
   Show/Hide
C33H38N4O2
 1
1
EC50 = 30 nM
   TI
   LI
   LO
   TS
CP0850007
3-(1H-Indol-3-yl)-N-phenethyl-2-[2-(2-pyridin-3-yl-acetylamino)-propionylamino]-propionamide
   Show/Hide
C29H31N5O3
 1
1
EC50 = 32 nM
   TI
   LI
   LO
   TS
CP0885576
2-Benzylamino-N-[2-(1H-indol-3-yl)-1-phenethylcarbamoyl-ethyl]-propionamide
   Show/Hide
C29H32N4O2
 1
1
EC50 = 46 nM
   TI
   LI
   LO
   TS
CP0885999
2-(2-1H-Indol-2-yl-acetylamino)-pentanedioic acid 5-amide 1-{[2-(1H-indol-3-yl)-1-phenethylcarbamoyl-ethyl]-amide}
   Show/Hide
C34H36N6O4
 1
1
EC50 = 57 nM
   TI
   LI
   LO
   TS
CP0448591
2-[2-(4-Benzyl-piperazin-1-yl)-acetylamino]-3-(1H-indol-3-yl)-N-phenethyl-propionamide
   Show/Hide
C32H37N5O2
 1
1
EC50 = 70 nM
   TI
   LI
   LO
   TS
CP0882243
3-(1H-Indol-3-yl)-2-[2-(2-1H-indol-2-yl-acetylamino)-propionylamino]-N-phenethyl-propionamide
   Show/Hide
C32H33N5O3
 1
1
EC50 = 79 nM
   TI
   LI
   LO
   TS
CP0855976
2-{2-[2-(4-Chloro-phenyl)-acetylamino]-propionylamino}-3-(1H-indol-3-yl)-N-phenethyl-propionamide
   Show/Hide
C30H31ClN4O3
 1
1
EC50 = 140 nM
   TI
   LI
   LO
   TS
CP0377472
(2S)-2-[[(2S)-2-[[(2S)-2-[3-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]propanoylamino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]hexanoic acid
   Show/Hide
C58H79N11O11
 1
1
EC50 = 151 nM
   TI
   LI
   LO
   TS
CP0847373
2-[3-(4-Chloro-phenyl)-propionylamino]-pentanedioic acid 5-amide 1-{[2-(1H-indol-3-yl)-1-phenethylcarbamoyl-ethyl]-amide}
   Show/Hide
C33H36ClN5O4
 1
1
EC50 = 230 nM
   TI
   LI
   LO
   TS
CP0857933
peptidomimetic
   Show/Hide
C27H27N5O2
 1
1
EC50 = 240 nM
   TI
   LI
   LO
   TS
CP0890387
3-(1H-Indol-3-yl)-N-phenethyl-2-[2-(2-1,2,3,4-tetrahydro-isoquinolin-1-yl-acetylamino)-propionylamino]-propionamide
   Show/Hide
C33H37N5O3
 1
1
EC50 = 310 nM
   TI
   LI
   LO
   TS
CP0885444
2-(2-Amino-3-phenyl-propionylamino)-pentanedioic acid 5-amide 1-{[2-(1H-indol-3-yl)-1-phenethylcarbamoyl-ethyl]-amide}
   Show/Hide
C33H38N6O4
 1
1
EC50 = 710 nM
   TI
   LI
   LO
   TS
CP0885912
2-Phenylacetylamino-pentanedioic acid 5-amide 1-{[2-(1H-indol-3-yl)-1-phenethylcarbamoyl-ethyl]-amide}
   Show/Hide
C32H35N5O4
 1
1
EC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0885728
2-[2-(4-Chloro-phenyl)-acetylamino]-pentanedioic acid 5-amide 1-{[2-(1H-indol-3-yl)-1-phenethylcarbamoyl-ethyl]-amide}
   Show/Hide
C32H34ClN5O4
 1
1
EC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0889393
peptidomimetic
   Show/Hide
C27H26ClN5O2
 1
1
EC50 = 2700 nM
   TI
   LI
   LO
   TS
CP0233482
(2S)-2-[(2-aminoacetyl)amino]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]butanediamide
   Show/Hide
C52H73N15O12S
 1
1
EC50 = 4500 nM
   TI
   LI
   LO
   TS
CP0384214
(2S)-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]butanediamide
   Show/Hide
C130H204N38O31S2
 1
1
EC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0857887
2-{2-[3-(4-Chloro-phenyl)-propionylamino]-propionylamino}-3-(1H-indol-3-yl)-N-phenethyl-propionamide
   Show/Hide
C31H33ClN4O3
 1
1
EC50 = 6400 nM
   TI
   LI
   LO
   TS
CP0847441
peptidomimetic
   Show/Hide
C31H29N5O2S
 1
1
EC50 = 7900 nM
   TI
   LI
   LO
   TS
CP0376662
10-(4-tert-butylphenyl)sulfonyl-5-(trifluoromethyl)-2,4,10,16-tetrazatetracyclo[9.8.0.03,8.012,17]nonadeca-1(11),3(8),4,6,12(17),13,15,18-octaene
   Show/Hide
C26H23F3N4O2S
 1
1
IC50 = 0.7 nM
   TI
   LI
   LO
   TS
CP0395607
6-(4-tert-butylphenyl)sulfonyl-7-methyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H24F3N3O2S
 1
1
IC50 = 0.9 nM
   TI
   LI
   LO
   TS
CP0423561
6-(4-tert-butylphenyl)sulfonyl-2-chloro-7,8-dimethyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H26ClN3O2S
 1
1
IC50 = 1.2 nM
   TI
   LI
   LO
   TS
CP0453510
7,8-dimethyl-6-(4-propan-2-ylphenyl)sulfonyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H24F3N3O2S
 1
1
IC50 = 1.6 nM
   TI
   LI
   LO
   TS
CP0441859
6-(4-tert-butylphenyl)sulfonyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepin-7-ol
   Show/Hide
C23H22F3N3O3S
 1
1
IC50 = 2.2 nM
   TI
   LI
   LO
   TS
CP0441853
6-(4-tert-butylphenyl)sulfonyl-7-chloro-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C23H21ClF3N3O2S
 1
1
IC50 = 3.2 nM
   TI
   LI
   LO
   TS
CP0414267
7,8-dimethyl-6-[4-(trifluoromethoxy)phenyl]sulfonyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C22H17F6N3O3S
 1
1
IC50 = 3.3 nM
   TI
   LI
   LO
   TS
CP0389466
6-(4-tert-butylphenyl)sulfonyl-7,8-dimethyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine-2-carbonitrile
   Show/Hide
C25H26N4O2S
 1
1
IC50 = 4.4 nM
   TI
   LI
   LO
   TS
CP0441855
2-[6-(4-tert-butylphenyl)sulfonyl-7-fluoro-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepin-8-yl]propan-2-ol
   Show/Hide
C26H27F4N3O3S
 1
1
IC50 = 5 nM
   TI
   LI
   LO
   TS
CP0441854
10-(4-tert-butylphenyl)sulfonyl-13-methyl-5-(trifluoromethyl)-2,4,10,12-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
   Show/Hide
C23H23F3N4O2S
 1
1
IC50 = 5.3 nM
   TI
   LI
   LO
   TS
CP0423563
6-(4-tert-butylphenyl)sulfonyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C23H22F3N3O2S
 1
1
IC50 = 5.5 nM
   TI
   LI
   LO
   TS
CP0523686
6-[4-(2-fluoropropan-2-yl)phenyl]sulfonyl-7,8-dimethyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H23F4N3O2S
 1
1
IC50 = 5.7 nM
   TI
   LI
   LO
   TS
CP0538376
2-[4-[[7,8-dimethyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepin-6-yl]sulfonyl]phenyl]-2-methylpropanenitrile
   Show/Hide
C25H23F3N4O2S
 1
1
IC50 = 5.7 nM
   TI
   LI
   LO
   TS
CP0377610
6-(4-tert-butylphenyl)sulfonyl-8-methyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H24F3N3O2S
 1
1
IC50 = 5.8 nM
   TI
   LI
   LO
   TS
CP0481364
7,8-dimethyl-2-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]sulfonyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C22H17F6N3O2S
 1
1
IC50 = 6.8 nM
   TI
   LI
   LO
   TS
CP0441856
6-(4-tert-butylphenyl)sulfonyl-2-chloro-3-fluoro-7,8-dimethyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H25ClFN3O2S
 1
1
IC50 = 8.9 nM
   TI
   LI
   LO
   TS
CP0395608
7,8-dimethyl-2-(trifluoromethyl)-6-[5-(trifluoromethyl)thiophen-2-yl]sulfonyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C20H15F6N3O2S2
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0423565
6-(4-tert-butylphenyl)sulfonyl-2,7,8-trimethyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C25H29N3O2S
 1
1
IC50 = 10 nM
   TI
   LI
   LO
   TS
CP0395609
7,8-dimethyl-2-(trifluoromethyl)-6-[5-(trifluoromethyl)thiophen-3-yl]sulfonyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C20H15F6N3O2S2
 1
1
IC50 = 14 nM
   TI
   LI
   LO
   TS
CP0423562
4-tert-butyl-2-[[7,8-dimethyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepin-6-yl]sulfonyl]-1,3-thiazole
   Show/Hide
C22H24F3N4O2S2+
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0395610
6-(4-tert-butylphenyl)sulfonyl-7,8-dimethyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H27N3O2S
 1
1
IC50 = 40 nM
   TI
   LI
   LO
   TS
CP0481277
7,8-dimethyl-6-(4-methylsulfonylphenyl)sulfonyl-2-(trifluoromethyl)-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C22H20F3N3O4S2
 1
1
IC50 = 73 nM
   TI
   LI
   LO
   TS
CP0441858
6-(4-tert-butylphenyl)sulfonyl-3-chloro-7,8-dimethyl-5,11-dihydropyrido[3,2-c][1,5]benzodiazepine
   Show/Hide
C24H26ClN3O2S
 1
1
IC50 = 430 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0313839
1-[4-(2,2-dimethylpropyl)-1H-imidazol-2-yl]-2-[4-(1H-pyrazol-1-yl)phenyl]propan-2-ol
   Show/Hide
C20H26N4O
 1
1 IC50 = 5 nM
CP0365995
4'-(2-(4-(2,2-dimethylbutyl)-1H-imidazol-2-yl)ethyl)biphenyl-2-carboxylic acid
   Show/Hide
C24H28N2O2
 1
1 IC50 = 11 nM
CP0465653
2-[4-(1H-pyrazol-1-yl)phenyl]-1-(4-{[1-(trifluoromethyl)cyclopropyl]methyl}-1H-imidazol-2-yl)propan-2-ol
   Show/Hide
C20H21F3N4O
 1
1 IC50 = 11 nM
CP0401480
2-(4-(2-(4-(2,2-dimethylbutyl)-1H-imidazol-2-yl)ethyl)phenyl)-5-fluoropyridine
   Show/Hide
C22H26FN3
 1
1 IC50 = 16 nM
CP0210908
1-[4-(2,2-dimethylpropyl)-1H-imidazol-2-yl]-2-[4-(5-fluoropyridin-2-yl)phenyl]propan-2-ol
   Show/Hide
C22H26FN3O
 1
1 IC50 = 17 nM
CP0210909
(2S)-1,1,1-trifluoro-2-[4-(1H-pyrazol-1-yl)phenyl]-3-(4-{[1-(trifluoromethyl)cyclopropyl]methyl}-1H-imidazol-2-yl)propan-2-ol
   Show/Hide
C20H18F6N4O
 2
1 IC50 = 27 nM
2 Ki = 3.7 nM
CP0298320
2-[4-(2,2-dimethylpropyl)-1H-imidazol-2-yl]-1-[4-(5-fluoropyridin-2-yl)phenyl]propan-2-ol
   Show/Hide
C22H26FN3O
 1
1 IC50 = 82 nM
CP0307797
4-(bicyclo[2.2.1]heptan-2-ylamino)-N-(isopropylcarbamoyl)pyridine-3-sulfonamide
   Show/Hide
C16H24N4O3S
 1
1 IC50 = 600 nM
CP0341603
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]pentanediamide
   Show/Hide
C57H76N14O10
 1
1 Ki = 0.36 nM
Clinical Information about the Protein
Target 1 ( Bombesin-like receptor 3 (BRS3) )
Target Type Literature-reported Target
Disease 1 Target-related Disease  1
1 Obesity [ICD-11: 5B81]
Investigative Drug(s) 1 Investigative Drug  1
1 MK-7725 Investigative
Obesity
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID Protein Name Protein Organism
PT05288 Bombesin receptor subtype-3 Rattus norvegicus, Rat
50% Identity
Protein ID Protein Name Protein Organism
PT05422 Bombesin receptor subtype-3 Mus musculus, Mouse